患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Recruiting

• The Influence of ABCB1?CYP3A4?CYP3A5?POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration
• Kidney Transplantation;Liver Transplantation
• Taiwan
• 2016-03-09

• Not recruiting

• Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)
• Carcinoma, Hepatocellular;Secondary
• Hong Kong
• 2016-03-09

• Not recruiting

• Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
• Chronic Graft Versus Host Disease;Chronic Graft Versus Host Disease;Chronic Graft Versus Host Disease
• Canada, France, Germany, Korea, Republic of, Spain, United Kingdom, United States
• 2016-02-24

• Not Recruiting

• Comparative efficacy and safety study of dolutegravir and lopinavir/ritonavir in second-line treatment
• infection, human immunodeficiency virus C02.782.815.616.400;A00-B99;C02.782.815.616.400
• Argentina, Brazil, Chile, China, Colombia, Kenya, Mexico, Peru, Romania, Russian Federation, South Africa, Thailand, Ukraine
• 2016-02-22

• Authorised

• Study for Efficacy and Tolerability of Entospletinib in Combination with Corticosteroids as First-Line Therapy in (cGVHD)
• Chronic Graft Versus Host Disease (cGVHD) MedDRA version: 20.0 Level: PT Classification code 10066261 Term: Chronic graft versus host disease System Organ Class: 10021428 - Immune system disorders ;Therapeutic area: Body processes [G] - Immune system processes [G12]
• Australia, Canada, France, Germany, Korea, Republic of, Spain, United Kingdom, United States
• 2016-02-12

• Not Recruiting

• Study to find the effects of new surgical technique in patients of Exo Duane Retraction syndrome
• exotropic duane retraction syndrome
• India
• 2016-02-01

• Recruiting

• The Effect of On-Line Hemodiafiltration Versus High Flux Hemodialysis on Hemodynamic Parameters in Patients With Intra-Dialytic Hypotension
• Intradialytic Hypotension;Intradialytic Hypotension;Intradialytic Hypotension;Intradialytic Hypotension
• Israel
• 2016-01-30

• Not recruiting

• The Benefit of ?n-Line High Convection Volume Hemodiafiltration Treatment Versus High Flow Dialysis on Reduction of Oxidative Stress and Health Related Quality of Life in Dialysis Patients
• End Stage Renal Disease;End Stage Renal Disease;End Stage Renal Disease;End Stage Renal Disease
• Israel
• 2016-01-30

• Not Recruiting

• A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
• Lung Cancer Non-small Cell Stage IV;C34 - Malignant neoplasm of bronchus and lung
• Austria, Belgium, Bulgaria, France, Germany, Ireland, Israel, Italy, Poland, Romania, Slovenia, Spain, Switzerland, United Kingdom
• 2016-01-26

• Recruiting

• Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
• Esophageal Squamous Cell Carcinoma
• China
• 2016-01-19

• Not recruiting

• Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
• Small Cell Lung Carcinoma;Carcinoma, Squamous Cell of Head and Neck;Stomach Neoplasms;Triple Negative Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Esophagogastric Junction Neoplasms;Carcinoma, Pancreatic Ductal;Esophageal Squamous Cell Carcinoma
• Japan, Korea, Republic of, United States
• 2016-01-11

• Not recruiting

• Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
• Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma;Gastric Cancer Third Line
• Australia, Belgium, Czech Republic, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Spain, United States
• 2015-12-04

• Not recruiting

• Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
• Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
• Australia, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States
• 2015-12-04

• Authorised

• Study of First Line MEDI4736 with or without Tremelimumab versus Standard of Care Chemotherapy in Advanced Unresectable Urothelial Bladder Cancer
• Adult patients (age =18 years) with histologically or cytologically documented transitional cell carcinoma (transitional cell and mixed transitional/non transitional cell histologies) of the urothelium (including renal pelvis, ureters, urinary bladder, and urethra), unresectable Stage IV (ie, =T4bN0M0 for bladder), and who are chemotherapy-naïve. MedDRA version: 20.0 Level: LLT Classification code 10022880 Term: Invasive bladder cancer stage IV System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
• Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
• 2015-11-10

• Not recruiting

• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
• Gastric Adenocarcinoma
• Australia, Belgium, Chile, Colombia, Czech Republic, Czechia, France, Germany, Hungary, Italy, Peru, Poland, Romania, Spain, Turkey, United Kingdom, United States
• 2015-09-08

• Not Recruiting

• A phase 4 clinical study to compare the safety and efficacy of LONQUEX® with NEULASTA® and Placebo in patients with Non-Small-Cell Lung Cancer treated with first-line chemotherapy
• Advanced squamous or non-squamous non-small-cell lung cancer (NSCLC) Stage IIIB/IV MedDRA version: 20.0 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
• Argentina, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, Chile, Croatia, Czech Republic, Greece, Hungary, Latvia, Mexico, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Turkey, Ukraine
• 2015-03-17

• Recruiting

• CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
• Metastatic Colorectal Cancer
• China
• 2017-06-28

• Recruiting

• Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC
• Lung Cancer;Non Small Cell Lung Cancer;Combination Chemotherapy;Apatinib;Lung Cancer;Non Small Cell Lung Cancer;Combination Chemotherapy;Apatinib;Lung Cancer;Non Small Cell Lung Cancer;Combination Chemotherapy;Apatinib;Lung Cancer;Non Small Cell Lung Cancer;Combination Chemotherapy;Apatinib
• China
• 2017-06-25

• Recruiting

• Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
• Breast Cancer;Breast Cancer;Breast Cancer;Breast Cancer
• China
• 2017-06-24

• Recruiting

• An open and one-armed exploration of Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-small Cell Lung Cancer
• cancer
• China
• 2017-06-21